LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) CTO Vukasin Paunovich sold 44,394 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.85, for a total value of $481,674.90. Following the sale, the chief technology officer directly owned 247,446 shares in the company, valued at $2,684,789.10. This trade represents a 15.21% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.
LifeStance Health Group Trading Up 6.3%
LFST opened at $12.23 on Thursday. The firm has a market cap of $4.74 billion, a price-to-earnings ratio of 94.08 and a beta of 1.14. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. LifeStance Health Group, Inc. has a 12 month low of $4.77 and a 12 month high of $12.43. The stock has a fifty day moving average price of $10.19 and a 200-day moving average price of $8.16.
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The company had revenue of $435.35 million for the quarter, compared to the consensus estimate of $414.58 million. During the same quarter last year, the company earned ($0.01) earnings per share. The firm’s revenue for the quarter was up 26.1% compared to the same quarter last year. As a group, equities research analysts anticipate that LifeStance Health Group, Inc. will post 0.15 earnings per share for the current fiscal year.
Analyst Ratings Changes
View Our Latest Research Report on LifeStance Health Group
Institutional Investors Weigh In On LifeStance Health Group
Several institutional investors have recently added to or reduced their stakes in LFST. Larson Financial Group LLC grew its stake in shares of LifeStance Health Group by 19,952.6% during the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after acquiring an additional 3,791 shares during the last quarter. KBC Group NV purchased a new position in shares of LifeStance Health Group in the 1st quarter valued at approximately $29,000. EverSource Wealth Advisors LLC boosted its stake in LifeStance Health Group by 359.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after purchasing an additional 5,404 shares in the last quarter. Bayesian Capital Management LP acquired a new stake in LifeStance Health Group in the 2nd quarter worth approximately $52,000. Finally, PNC Financial Services Group Inc. boosted its stake in LifeStance Health Group by 615.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock worth $59,000 after purchasing an additional 7,987 shares in the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.
Key Headlines Impacting LifeStance Health Group
Here are the key news stories impacting LifeStance Health Group this week:
- Positive Sentiment: Analyst support remains strong. Morgan Stanley reaffirmed its Buy rating, while BTIG Research recently raised its price target from $15 to $16 and maintained a Buy rating. These actions reinforce the bullish view of LifeStance’s growth prospects. Morgan Stanley Reaffirms Their Buy Rating on LifeStance Health Group
- Positive Sentiment: LifeStance’s earnings momentum is supporting the stock. The company recently exceeded quarterly earnings and revenue expectations, with revenue rising 26.1% year over year. Zacks also upgraded LFST to a Rank #2 (Buy), citing improving earnings prospects. LifeStance Health Upgraded to Buy
- Positive Sentiment: Investor interest has pushed LFST to a new 52-week high. The move reflects strong recent momentum and growing optimism about the company’s fundamentals, although the elevated valuation increases the importance of continued execution. LifeStance Health Group Sets New 1-Year High
- Neutral Sentiment: LifeStance released survey findings highlighting demand for mental-health services integrated into perimenopause and menopause care. The announcement supports awareness of a potential growth niche but does not directly change financial guidance. LifeStance Survey on Menopause Care
- Negative Sentiment: Several insiders reduced their holdings. Major shareholder TPG GP A sold 13.64 million shares for approximately $144.9 million, while the COO and CTO sold shares worth about $519,845 and $481,675, respectively. Although each seller retained a substantial position, the transactions may raise concerns about profit-taking and near-term selling pressure. LifeStance Insider Sale Filing
About LifeStance Health Group
LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.
The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.
Read More
- Five stocks we like better than LifeStance Health Group
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
